Synonym
Acremonic acid; Cephalosporin P; Cephalosporin P1
IUPAC/Chemical Name
(3alpha,4alpha,6alpha,7beta,8alpha,9beta,13alpha,14beta,16beta,17Z)-6,16-Bis(acetyloxy)-3,7-dihydroxy-29-nordammara-17(20),24-dien-21-oic acid
InChi Key
YJJWILCYIMMPAS-NSENTHHTSA-N
InChi Code
InChI=1S/C33H50O8/c1-17(2)10-9-11-21(30(38)39)26-22-12-13-25-31(6)15-14-23(36)18(3)27(31)28(41-20(5)35)29(37)33(25,8)32(22,7)16-24(26)40-19(4)34/h10,18,22-25,27-29,36-37H,9,11-16H2,1-8H3,(H,38,39)/b26-21-/t18-,22+,23-,24+,25+,27?,28-,29+,31-,32+,33-/m1/s1
SMILES Code
C[C@@H](C1[C@@H](OC(C)=O)[C@H](O)[C@]([C@@](C[C@@H]/2OC(C)=O)3C)4C)[C@H](O)CC[C@]1(C)[C@]4([H])CC[C@@]3([H])C2=C(C(O)=O)/CC/C=C(C)\C
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
574.76
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Lahra MM, Enriquez RP. Australian Meningococcal Surveillance Programme annual report, 2013. Commun Dis Intell Q Rep. 2014 Dec 31;38(4):E301-8. PubMed PMID: 25631592.
2: Chang KH, Yeh CM, Yeh CY, Huang CC, Hsu KS. Neonatal dexamethasone treatment exacerbates hypoxic-ischemic brain injury. Mol Brain. 2013 Apr 18;6:18. doi: 10.1186/1756-6606-6-18. PubMed PMID: 23594486; PubMed Central PMCID: PMC3637314.
3: Pal A, Samanta TB. Beta-lactamase-free penicillin amidase from Alcaligenes sp.: isolation strategy, strain characteristics, and enzyme immobilization. Curr Microbiol. 1999 Nov;39(5):244-8. PubMed PMID: 10489431.
4: Shehab S, Keller N, Barkay A, Leitner L, Leventhal A, Block C. Failure of mass antibiotic prophylaxis to control a prolonged outbreak of meningococcal disease in an Israeli village. Eur J Clin Microbiol Infect Dis. 1998 Nov;17(11):749-53. PubMed PMID: 9923513.
5: Svensson HP, Frank IS, Berry KK, Senter PD. Therapeutic effects of monoclonal antibody-beta-lactamase conjugates in combination with a nitrogen mustard anticancer prodrug in models of human renal cell carcinoma. J Med Chem. 1998 Apr 23;41(9):1507-12. PubMed PMID: 9554883.
6: Moulin F, Dumontier S, Saulnier P, Chachaty E, Loubeyre C, Brugières L, Andremont A. Surveillance of intestinal colonization and of infection by vancomycin-resistant enterococci in hospitalized cancer patients. Clin Microbiol Infect. 1996 Feb;2(3):192-201. PubMed PMID: 11866843.
7: Kerr DE, Schreiber GJ, Vrudhula VM, Svensson HP, Hellström I, Hellström KE, Senter PD. Regressions and cures of melanoma xenografts following treatment with monoclonal antibody beta-lactamase conjugates in combination with anticancer prodrugs. Cancer Res. 1995 Aug 15;55(16):3558-63. PubMed PMID: 7627964.
8: Svensson HP, Vrudhula VM, Emswiler JE, MacMaster JF, Cosand WL, Senter PD, Wallace PM. In vitro and in vivo activities of a doxorubicin prodrug in combination with monoclonal antibody beta-lactamase conjugates. Cancer Res. 1995 Jun 1;55(11):2357-65. PubMed PMID: 7757987.
9: Vrudhula VM, Svensson HP, Kennedy KA, Senter PD, Wallace PM. Antitumor activities of a cephalosporin prodrug in combination with monoclonal antibody-beta-lactamase conjugates. Bioconjug Chem. 1993 Sep-Oct;4(5):334-40. PubMed PMID: 8274516.
